CytoDyn Inc. (CYDY) › Operating IncomeCytoDyn Inc. (CYDY) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2011: -$3.70M2012: -$7.46M2013: -$7.99M2014: -$8.11M2015: -$19.60M2016: -$21.18M2017: -$27.33M2018: -$45.92M2019: -$55.85M2020: -$74.65M2021: -$104.60M2022: -$145.40M2023: -$40.58M2024: -$18.06M2025: $9.66M$9.66M2011Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025$9.66M+153.5%2024-$18.06M+55.5%2023-$40.58M+72.1%2022-$145.40M-39.0%2021-$104.60M-40.1%2020-$74.65M-33.7%2019-$55.85M-21.6%2018-$45.92M-68.0%2017-$27.33M-29.1%2016-$21.18M-8.1%2015-$19.60M-141.6%2014-$8.11M-1.5%2013-$7.99M-7.2%2012-$7.46M-101.6%2011-$3.70M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share